NL192343B - 17O-substituted androsta- (1,) 4- (di) en-3-on-17β-carboxylic acid compounds with anti-inflammatory activity and pharmaceutical compositions containing these compounds. - Google Patents

17O-substituted androsta- (1,) 4- (di) en-3-on-17β-carboxylic acid compounds with anti-inflammatory activity and pharmaceutical compositions containing these compounds.

Info

Publication number
NL192343B
NL192343B NL8103315A NL8103315A NL192343B NL 192343 B NL192343 B NL 192343B NL 8103315 A NL8103315 A NL 8103315A NL 8103315 A NL8103315 A NL 8103315A NL 192343 B NL192343 B NL 192343B
Authority
NL
Netherlands
Prior art keywords
compounds
carboxylic acid
pharmaceutical compositions
compositions containing
inflammatory activity
Prior art date
Application number
NL8103315A
Other languages
Dutch (nl)
Other versions
NL192343C (en
NL8103315A (en
Original Assignee
Nicholas Stephen Bodor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Stephen Bodor Dr filed Critical Nicholas Stephen Bodor Dr
Publication of NL8103315A publication Critical patent/NL8103315A/en
Publication of NL192343B publication Critical patent/NL192343B/en
Application granted granted Critical
Publication of NL192343C publication Critical patent/NL192343C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8103315A 1980-07-10 1981-07-10 17O-substituted androsta- (1,) 4- (di) en-3-on-17β-carboxylic acid compounds with anti-inflammatory activity and pharmaceutical compositions containing these compounds. NL192343C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16845380A 1980-07-10 1980-07-10
US16845380 1980-07-10
US26578581A 1981-05-21 1981-05-21
US26578581 1981-05-21

Publications (3)

Publication Number Publication Date
NL8103315A NL8103315A (en) 1982-02-01
NL192343B true NL192343B (en) 1997-02-03
NL192343C NL192343C (en) 1997-06-04

Family

ID=26864131

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8103315A NL192343C (en) 1980-07-10 1981-07-10 17O-substituted androsta- (1,) 4- (di) en-3-on-17β-carboxylic acid compounds with anti-inflammatory activity and pharmaceutical compositions containing these compounds.

Country Status (17)

Country Link
KR (2) KR860000266B1 (en)
AT (1) AT379816B (en)
AU (1) AU540898B2 (en)
CA (1) CA1174667A (en)
CH (1) CH648856A5 (en)
DE (1) DE3126732C2 (en)
DK (1) DK165837C (en)
ES (2) ES504340A0 (en)
FI (1) FI71748C (en)
FR (1) FR2486529A1 (en)
GB (1) GB2079755B (en)
IT (1) IT1205446B (en)
NL (1) NL192343C (en)
NO (1) NO163285C (en)
PH (1) PH25874A (en)
PT (1) PT73348B (en)
SE (1) SE449106B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2137206B (en) * 1980-02-15 1985-04-03 Glaxo Group Ltd Androstane 17-carbothioc acid derivatives
JPS6041607A (en) * 1983-08-12 1985-03-05 Otsuka Pharmaceut Co Ltd Ointment base
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
SE8501693D0 (en) * 1985-04-04 1985-04-04 Draco Ab NOVEL 16,17-ACETALSUBSTITUTED ANDROSTANE-17BETA-CARBOXYLIC ACID ESTERS
DE3786174T2 (en) * 1987-10-13 1993-10-21 Nicholas S Bodor SOFT STEROIDS WITH ANTI-INFLAMMATION EFFECT.
DE4025342A1 (en) * 1990-08-10 1992-02-13 Hoechst Ag CORTICOID-17-ALKYLCARBONATE SUBSTITUTED IN 17-POSITION, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THE SAME
JP2000513380A (en) * 1997-06-30 2000-10-10 グラクソ、グループ、リミテッド Compound
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
PT2348032E (en) 2000-08-05 2015-10-14 Glaxo Group Ltd 6.alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
UA82323C2 (en) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
WO2006072599A2 (en) 2005-01-10 2006-07-13 Glaxo Group Limited Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions
TWI374147B (en) * 2006-01-27 2012-10-11 Sun Pharma Advance Res Company Ltd Novel 11β-hydroxyandrosta-4-ene-3-ones
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
CN101942001B (en) * 2010-08-24 2013-02-06 山东省医药工业研究所 Purification method of loteprednol etabonate
CN103183714A (en) * 2011-12-29 2013-07-03 山东方明药业集团股份有限公司 Synthetic method for loteprednol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384372A (en) * 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
DE2735110A1 (en) * 1977-08-04 1979-02-15 Hoechst Ag CORTICOID-17-ALKYLCARBONATE AND METHOD FOR THE PRODUCTION THEREOF
IT1114534B (en) * 1978-02-08 1986-01-27 Glaxo Group Ltd ANTI-INFLAMMATORY STEROID OF THE ANDROSTANE SERIES COMPOSITIONS THAT CONTAIN IT AND PROCEDURE TO PRODUCE IT
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
DE2817988A1 (en) * 1978-04-25 1979-11-08 Hoechst Ag CORTICOID 17-ALKYLCARBONATE AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
DK302181A (en) 1982-01-11
SE449106B (en) 1987-04-06
FR2486529A1 (en) 1982-01-15
ES8300785A1 (en) 1982-12-01
GB2079755A (en) 1982-01-27
GB2079755B (en) 1985-01-30
DE3126732C2 (en) 1987-04-30
IT8105186A0 (en) 1981-07-09
KR860000266B1 (en) 1986-03-22
AU540898B2 (en) 1984-12-06
NL192343C (en) 1997-06-04
SE8104132L (en) 1982-01-11
ES504340A0 (en) 1982-12-01
ES514633A0 (en) 1983-06-16
CH648856A5 (en) 1985-04-15
PT73348B (en) 1982-09-23
FI71748C (en) 1987-02-09
KR830006327A (en) 1983-09-24
FI71748B (en) 1986-10-31
IT1205446B (en) 1989-03-23
NO163285C (en) 1990-05-02
AT379816B (en) 1986-03-10
NO812344L (en) 1982-01-11
ATA307081A (en) 1985-07-15
KR850002759A (en) 1985-05-15
DE3126732A1 (en) 1982-03-25
FI812175L (en) 1982-01-11
NO163285B (en) 1990-01-22
FR2486529B1 (en) 1985-01-04
CA1174667A (en) 1984-09-18
DK165837B (en) 1993-01-25
ES8306767A1 (en) 1983-06-16
KR860000452B1 (en) 1986-04-26
PH25874A (en) 1991-12-02
NL8103315A (en) 1982-02-01
PT73348A (en) 1981-08-01
AU7259181A (en) 1982-01-14
DK165837C (en) 1993-06-21

Similar Documents

Publication Publication Date Title
NL192343B (en) 17O-substituted androsta- (1,) 4- (di) en-3-on-17β-carboxylic acid compounds with anti-inflammatory activity and pharmaceutical compositions containing these compounds.
NL192201B (en) Pharmacologically active phenylaminoalkylcyclobutane compounds and compositions containing these compounds.
IT8220611A0 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS.
DE3586545D1 (en) INCREASED PAINLESSNESS PHARMACEUTICAL COMPOSITIONS.
MX9203176A (en) 1,2,4-TRIAZOLONES SUBSTITUTED WITH PHENOXYETHYLL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE3669104D1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING ASCORBIN ACID DERIVATIVES.
IT1190824B (en) PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
NL990010I1 (en) Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-one derivatives and pharmaceutical compositions containing these derivatives.
NL192265B (en) Penem carboxylic acid compounds and pharmaceutical preparations containing these compounds.
NL7804725A (en) 4-AMINOMETHYL-1- (3,3,3-TRIARYPROPYL) -4ARYLPIPERIDINS AND THEIR DERIVATIVES, AND MEDICINES WITH ANTI-DIARRHEA ACTIVITY, CONTAINING THOSE COMPOUNDS AS AN ACTIVE COMPONENT.
NL193022B (en) N-acyl-alpha-amino-alpha, omega-alkanedicarboxylic acid amides and pharmaceutical composition containing such a compound.
IT7926662A0 (en) PHARMACEUTICAL COMPOSITION CONTAINING 3,4-DI-HYDRO-3-OXO-2-QUINOXALINES.
NL188645C (en) 1-AZAXANTHON-3-CARBONIC ACID COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
ATE5188T1 (en) PHENYLAKAN ACID DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
IT7927243A0 (en) FOR THEIR PREPARATION AND TRIAZINONE COMPOUNDS, PROCEDURES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IT1210935B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
NL7906624A (en) 3,7-SUBSTITUTED-3-CEFEM-4-CARBONIC ACID COMPOUNDS AND THEIR PREPARATION.
NL193023B (en) Indolylalkanoic acid derivative, as well as anti-inflammatory drug.
IT8320468A0 (en) NEW COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
BE892911A (en) NITROIMIDAZOLES HAVING TRICHOMONACID ACTIVITY, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IT8123659A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AMYTRIPTILINE.
BE892709A (en) NEW TOPICAL PHARMACEUTICAL COMPOSITIONS
NL8100209A (en) METHYLPENAMCARBONIC ACID SULPHONES, SALTS AND THEIR ESTERS, AND MEDICINAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT.
NL7803977A (en) 2-HYDROXY-2- (5-ISOXAZOLYLMETHYL) -6,7-BENZOMORPHANES, ACID ADDITION SALTS THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
DE3689278D1 (en) Photopolymerizable compositions containing substituted pyrylium salts as photoinitiators and the pyrylium salts used.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
A85 Still pending on 85-01-01
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: BODOR. DR. NICHOLAS STEPHEN -

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20010710